“THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies” (2020) Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021013. doi:10.4084/mjhid.2021.013.